These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1135210)

  • 1. [Indicator method of determination of tuberculostatic drugs in the urine].
    Shpits RO; Romanenko MD
    Probl Tuberk; 1975; (3):76-8. PubMed ID: 1135210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modified method for indicating antitubercular agents in the urine in tuberculosis].
    Solov'eva AS; Lukomskaia VM
    Lab Delo; 1980; (12):756-7. PubMed ID: 6163900
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary excretion of lead in patients treated with tuberculostatic drugs].
    Kraczkowski J; Wójcik A; Borzecki Z
    Ann Univ Mariae Curie Sklodowska Med; 1986; 41():61-5. PubMed ID: 3154060
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory monitoring by urine analysis of pulmonary tuberculosis patient compliance in taking 2d series preparations and isoniazid derivatives].
    Radkevich RA; Utkin VV; Guseva TM
    Lab Delo; 1978; (2):84-6. PubMed ID: 76009
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the dynamics of 17-ketosteroid content in the urine of tuberculous patients treated with antibacterial drugs and prednisolone].
    Tsigel'nik AIa; Volkova KI
    Probl Tuberk; 1965; 43(11):65-71. PubMed ID: 5875737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Method of control of administration of different tuberculostatic preparations by means of urine analysis with a single reagent].
    Rudoĭ NM; Simonian LK
    Lab Delo; 1975; (10):614-6. PubMed ID: 54465
    [No Abstract]   [Full Text] [Related]  

  • 7. [Express-method for determination of some antitubercular chemopreparations in urine].
    Shpits RO; Romanenko MD
    Lab Delo; 1968; 8():454-6. PubMed ID: 4184041
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tuberculostatic test in the treatment of pulmonary tuberculosis with 1st and 2d class drugs].
    Gur'ian IE; Svitneva AS; Tarasova EF
    Probl Tuberk; 1971; 49(12):33-6. PubMed ID: 5003602
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of initial intermittent chemotherapy with classical tuberculostatic drugs, evaluated by study of the negation of sputum cultures].
    Anastasatu C; Kaufman S; Dinulică E; Negulescu E; Kercea V
    Ftiziologia; 1971; 20(3):233-8. PubMed ID: 5164058
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis].
    Navrotskiĭ VV; Pertsovskiĭ AI; Belogurova VP
    Probl Tuberk; 1968; 46(11):39-43. PubMed ID: 5711714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Negativation of developing pulmonary tuberculosis under tuberculostatic therapy].
    Cosemans J; Gyselen A; Verbist L; Doms F
    Acta Tuberc Pneumol Belg; 1968; 59(1):337-49. PubMed ID: 5739133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Follow-up studies on patients with chronic pulmonary tuberculosis treated with secondary tuberculostatic agents].
    Böszörményi M; Faust I; Barát I; Schweiger O
    Probl Tuberk; 1965; 43(8):39-45. PubMed ID: 5869918
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immediate results obtained with intermittent treatment with classical tuberculostatic drugs in tuberculosis in children].
    Tonceanu S; Carp G; Bazacliu E; Sabău I
    Ftiziologia; 1974 May; 23(3):265-8. PubMed ID: 4546327
    [No Abstract]   [Full Text] [Related]  

  • 14. [Why cavernous tuberculosis was a fatal disease before the invention of tuberculostatic drugs].
    Seri I
    Orv Hetil; 1992 Nov; 133(45):2941-2. PubMed ID: 1437117
    [No Abstract]   [Full Text] [Related]  

  • 15. [A method for the determination of the resistance of Mycobacterium tuberculosis to classical antitubercular drugs in percentages].
    Zduńczyk-Pawelek H; Kostrzewska K; Blitek-Golc D
    Gruzlica; 1966 Feb; 34(2):89-94. PubMed ID: 4957541
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA; Utkin VV; Korotaev GA; Golitsina LV
    Probl Tuberk; 1967; 45(5):29-33. PubMed ID: 5617941
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacilliferous tuberculosis and sensitivity of Koch bacilli to tuberculostatic drugs (current situation in a French hospital service)].
    Oudet P
    Arch Monaldi; 1972; 27(4):403-17. PubMed ID: 4217597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of pulmonary tuberculosis by the intravenous infusion of tuberculostatic preparations].
    Volynskiĭ IP
    Voen Med Zh; 1974 Feb; (2):69-70. PubMed ID: 4456792
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of adolescents with various forms of tuberculosis using 2d-series tuberculostatic preparations].
    Rushchak VA
    Vrach Delo; 1971 Oct; 10():90-2. PubMed ID: 5316836
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of saturation of Mycobacterium tuberculosis--a theoretical basis of the method of mazimum concentration of tuberculostatic preparations].
    Bondarev IM
    Probl Tuberk; 1974; 52(6):58-64. PubMed ID: 4211415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.